Thus, in this study we sought to determine levels of SCAND3 and Myo1g methylation in the tissue and serum of HCC patients and whether they might be useful as non-invasive biomarkers for the diagnosis and management of HCC. The gene discussed is MYO1G; the disease is hepatocellular carcinoma.